BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Oscient Pharmaceuticals Corporation 

1000 Winter Street, Suite 2200

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-398-2300 Fax: 781-893-9535


SEARCH JOBS



Segment
Genomics





 Company News
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease From Oscient Pharmaceuticals Corporation (OSCI) And EPIX Pharmaceuticals, Inc. (EPIX) 12/16/2009 8:53:27 AM    More...
Oscient Pharmaceuticals Corporation (OSCI) Files for Bankruptcy; Sell its Antibiotic Drug Factive to Cornerstone Therapeutics Inc. Unit for $5 Million 7/14/2009 7:20:20 AM    More...
Oscient Pharmaceuticals Corporation (OSCI) to Cut Sales Force 6/12/2009 7:21:18 AM    More...
Oscient Pharmaceuticals Corporation (OSCI) Receives NASDAQ Letter Regarding Delay in Filing Form 10-Q 5/26/2009 10:31:46 AM    More...
Oscient Pharmaceuticals Corporation (OSCI) Reports Fourth Quarter and Full Year 2008 Financial Results 3/25/2009 10:29:55 AM    More...
Oscient Pharmaceuticals Corporation (OSCI) Gets Going Concern Notice; Looking at Alternative Including Sale of Company 3/25/2009 8:43:21 AM    More...
NASDAQ Extends Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Pharmaceuticals Corporation (OSCI) Compliance Period Extended to October 6, 2009 3/24/2009 9:29:41 AM    More...
Oscient Pharmaceuticals Corporation (OSCI) Restructures Commercial Organization; Reduces Workforce by 32% 2/12/2009 7:21:02 AM    More...
Oscient Pharmaceuticals Corporation (OSCI) Extends Maturity of its Privately Placed 5% Convertible Promissory Notes 1/28/2009 10:21:00 AM    More...
NASDAQ Extends Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Pharmaceuticals Corporation (OSCI) Compliance Period Extended to July 6, 2009 12/23/2008 8:34:19 AM    More...
12345678910...

//-->